Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies

Abstract Background: Eribulin mesylate is currently approved in the United States and Europe for the treatment of metastatic breast cancer (MBC). Scope: The objective of this retrospective study is to find specific predictive criteria related to patient or tumor characteristics in order to select pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sabrina Rossi (Author), Alessandra Cassano (Author), Antonia Strippoli (Author), Giovanni Schinzari (Author), Ettore D'Argento (Author), Michele Basso (Author), Carlo Barone (Author)
Formato: Livro
Publicado em: BioExcel Publishing Ltd, 2017-11-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível